Summary
Histogenetic similarities in the female geninal system suggest that a group of cancers from the coelomic epithelium may have a common sensitivity to cytotoxic treatment. A total of 24 patients with evaluable gynecologic cancer were treated with a new combination regimen consisting of cisplatin (50 mg/m2), Adriamycin (50 mg/m2), and ifosfamide (1 g/m2×5days) (PAI) given in five courses at 4-week intervals. The tumors included ten cervical, four endometrial, seven ovarian, and three peritoneal cancers. In all, 20 of our patients had recurrent disease and had previously received other cytotoxic treatment, including radiation (11 cases), cisplatin-containing chemotherapy (8 cases), or both (1 case). As a schedule modification, PAI plus bleomycin (20 mg/m2, on days 1 and 8) was recommended for tumors containing squamous components. According to the response criteria of the International Union Against Cancer (UICC), a 96% response rate was obtained (cervical, 9/10; endometrial, 4/4; ovarian, 7/7; peritoneal, 3/3). Of 23 responders 8 (35%) achieved a complete remission. The dose-limiting side effect of the PAI regimen was hematologic toxicity: grade 4 leukopenia was observed in 92% of patients, and grade 4 thrombocytopenia was seen in 175. However, the myelosuppresion reversed spontaneously within 3 weeks, and none of the patients was incapable of completing the planned treatment courses. The results sugest that PAI combination chemotherapy is effective and can be used in the management of patients with gynecologic malignancies derived from the coelomic epithelium (müllerian tumor group).
Similar content being viewed by others
References
Gersell DJ, Mazoujian G, Mutch DG, Rudloff MA (1988) Small cell carcinoma of the cervix. A clinicopathologic, ultrastructural, and immunocytochemical study of 15 cases. Am J Surg Pathol 12:684
Goldin A (1982) Ifosfamide in experimental tumor systems. Semin Oncol 9 [Suppl 1]:14
Goldin A (1982) Dosing and sequencing for antineoplastic synergism. Cancer 54:1155
Hermanek P, Sobin LH (eds) (1987) International Union Against Cancer (UICC): TNM classification of malignant tumours, 4th edn. Springer, Berlin Heidelberg New York
Lauchlan SC (1968) Conceptual unity of the müllerian tumor group. Cancer 22:601
Lauchlan SC (1972) The secondary müllerian systems Obstet Gynecol Surv 27:133
Meanwell CA, Mould JJ, Blackledge G, Lawton FG, Stuart NSA, Kavanagh J, Latief TN, Spooner D, Chetiyawardana AD (1986) Phase II study of ifosfamide in cervical cancer. Cancer Treat Rep 70:727
Miller AB, Hoogstraten B, Staquet M and Winkler A (1981) Reporting results of cancer treatment, Cancer 47:207
Pettersson F (ed) (1988) Annual report of treatment results of gynecological cancer, vol 20. International Federation of Gynecology and Obstetrics, Radiumhemmet, Stockholm
Piver MS, Barlow JJ, Vongtama V, Webster J (1974) Hydroxyurea and radiation therapy in advanced cervical cancer. Am J Obstet Gynecol 120:969
Slotman BJ, Rao R (1988) Ovarian cancer (review). Anticancer Res 8:417
Turbow MM, Ballon SC, Sikic BI, Koretz MM (1985) Cisplatin, doxorubicin and cyclophosphamide chemotherapy for advanced endometrial carcinoma. Cancer Treat Rep 69:465
Woodman RJ, Sirica AE, Gang M, Kline I, Venditti JM (1973) The enhanced therapeutic effect of cisplatinum(II)diamminodichloride against L1210 leukemia when combined with cyclophosphamide or 1,2-bis(3,5-dioxopiperazine-1-yl)propane or several other antitumor agents. Chemotherapy 18:169
Yakushiji M, Tsunawaki A, Nishida T, Nishimura H, Natsuaki Y, Inoue T, Kato T (1981) Chemotherapy of malignant ovarian tumors; therapeutic results of ifosfamide. Acta Obstet Gynaecol Jpn Engl Ed 33:1071
Author information
Authors and Affiliations
Additional information
Supported in part by a fellowship grant from the Department of Obstetrics and Gynecology, Kurume University
Rights and permissions
About this article
Cite this article
Nishida, T., Nagasue, N. & Yakushiji, M. Treatment of gynecological malignancies with a combination of cisplatin, Adriamycin and ifosfamide. Cancer Chemother. Pharmacol. 26 (Suppl 1), S39–S42 (1990). https://doi.org/10.1007/BF00685416
Issue Date:
DOI: https://doi.org/10.1007/BF00685416